SCHEMBL25335802

SCHEMBL25335802

O=C(O)N1CC(O)(C(F)(F)F)C[C@H]1CO

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.31
PDK2 Q15119 1/20 0.30
POLB P06746 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20488133 1.00 RORC (0.31) RORCPDK2POLBL3MBTL1
SCHEMBL21790284 0.79 NR1H2 (0.38)
SCHEMBL25366788 0.79 NR1H2 (0.38)
SCHEMBL25335347 0.76 ATM (0.33)
SCHEMBL13858417 0.75 RIPK1 (0.42) RORCPOLBL3MBTL1
SCHEMBL15320412 0.75 RIPK1 (0.42) RORCPOLBL3MBTL1
SCHEMBL16992110 0.75 RIPK1 (0.42) RORCPOLBL3MBTL1
SCHEMBL25333045 0.75
SCHEMBL20488986 0.75
SCHEMBL16774688 0.74 POLB (0.32) POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed
WO-2023133174-A1 PROTEASE INHIBITORS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION MERCK SHARP & DOHME LLC (US) 2023-07-13 WO disclosed